Literature DB >> 26483442

Retinopathy of prematurity in Korean infants with birthweight greater than 1500 g.

Shin Hae Park1, Hae Ri Yum2, Seonjoo Kim1, Young Chun Lee3.   

Abstract

OBJECTIVE: To determine the incidence and clinical features of, and risk factors for, retinopathy of prematurity (ROP) in Korean infants with birthweight (BW) >1500 g.
METHODS: A total of 201 consecutive infants with BW >1500 g from January 2009 to December 2013 were included. The location and maximal stage of retinopathy observed were recorded for each infant. The associated systemic and maternal risk factors in infants with mild or absent ROP were compared with those in infants with treatment-requiring ROP.
RESULTS: The total incidence of ROP was 11.94% and that of treatment-requiring ROP was 3.98%. Two patients with gestational age (GA) >32 weeks and BW >1500 g had treatment-requiring ROP. 15 eyes from eight infants with type I ROP required laser photocoagulation. The mean BWs and GAs in the treatment-requiring ROP group were significantly lower than those in the no or mild ROP group. Total duration of oxygen supplementation, surfactant usage, respiratory distress syndrome, bronchopulmonary dysplasia, antibiotic use for more than 14 days and the number of ROP-associated risk factors significantly increased the likelihood of treatment-requiring ROP (p=0.002, p=0.008, p=0.008, p=0.000, p=0.015, and p=0.004, respectively).
CONCLUSION: Our study confirmed that treatment-requiring ROP does occur in infants with BW >1500 g. To avoid overlooking infants with vision-threatening ROP, an evaluation of the data from larger BW preterm infants is advisable so that screening guidelines in neonatal care units may be refined. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Mesh:

Year:  2015        PMID: 26483442     DOI: 10.1136/bjophthalmol-2015-306960

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  7 in total

Review 1.  Retinopathy of prematurity: a review of risk factors and their clinical significance.

Authors:  Sang Jin Kim; Alexander D Port; Ryan Swan; J Peter Campbell; R V Paul Chan; Michael F Chiang
Journal:  Surv Ophthalmol       Date:  2018-04-19       Impact factor: 6.048

2.  Characteristic clinical features associated with aggressive posterior retinopathy of prematurity.

Authors:  Y J Ahn; K E Hong; H R Yum; J H Lee; K S Kim; Y A Youn; S H Park
Journal:  Eye (Lond)       Date:  2017-02-24       Impact factor: 3.775

3.  Risk Factors for Retinopathy of Prematurity in Premature Born Children.

Authors:  Jasmina Alajbegovic-Halimic; Denisa Zvizdic; Emina Alimanovic-Halilovic; Irena Dodik; Sanela Duvnjak
Journal:  Med Arch       Date:  2015-12

4.  Chorioamnionitis as a risk factor for retinopathy of prematurity: An updated systematic review and meta-analysis.

Authors:  Eduardo Villamor-Martinez; Giacomo Cavallaro; Genny Raffaeli; Owais M M Mohammed Rahim; Silvia Gulden; Amro M T Ghazi; Fabio Mosca; Pieter Degraeuwe; Eduardo Villamor
Journal:  PLoS One       Date:  2018-10-17       Impact factor: 3.240

5.  Current evidence and outcomes for retinopathy of prematurity prevention: insight into novel maternal and placental contributions.

Authors:  Lara Carroll; Leah A Owen
Journal:  Explor Med       Date:  2020-02-29

6.  Nationwide incidence and treatment pattern of retinopathy of prematurity in South Korea using the 2007-2018 national health insurance claims data.

Authors:  Eun Hee Hong; Yong Un Shin; Gi Hwan Bae; Young Jin Choi; Seong Joon Ahn; Lucia Sobrin; Rimkyung Hong; Inah Kim; Heeyoon Cho
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

7.  Identification of candidate genes and pathways in retinopathy of prematurity by whole exome sequencing of preterm infants enriched in phenotypic extremes.

Authors:  Sang Jin Kim; Kemal Sonmez; Ryan Swan; J Peter Campbell; Susan Ostmo; R V Paul Chan; Aaron Nagiel; Kimberly A Drenser; Audina M Berrocal; Jason D Horowitz; Xiaohui Li; Yii-Der Ida Chen; Kent D Taylor; Charles Simmons; Jerome I Rotter; Michael F Chiang
Journal:  Sci Rep       Date:  2021-03-02       Impact factor: 4.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.